Grace Therapeutics, Inc. · NASDAQ:GRCE

Grace Therapeutics, Inc. insider trades

Grace Therapeutics, Inc.'s insiders made 27 buys and 0 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

TradeTradeSharesPriceValueDate
Opaleye Management Inc.
10% owner
Buy2,974USD 1.73US$5,131Nov 18, 2026
Opaleye Management Inc.
10% owner
Buy29,207USD 1.72US$50,292Nov 17, 2026
Opaleye Management Inc.
10% owner
Buy15,879USD 1.76US$28,012Nov 16, 2026
Opaleye Management Inc.
10% owner
Buy3,087USD 1.77US$5,478Nov 5, 2026
Opaleye Management Inc.
10% owner
Buy5,027USD 1.80US$9,060Nov 4, 2026
Opaleye Management Inc.
10% owner
Buy10,328USD 1.79US$18,481Nov 3, 2026
Opaleye Management Inc.
10% owner
Buy66,411USD 1.77US$117KOct 26, 2026
Opaleye Management Inc.
10% owner
Buy21,390USD 1.93US$41,193Oct 22, 2026
Opaleye Management Inc.
10% owner
Buy4,256USD 1.88US$8,001Oct 19, 2026
Opaleye Management Inc.
10% owner
Buy36,347USD 1.89US$68,758Oct 16, 2026
Opaleye Management Inc.
10% owner
Buy23,485USD 1.95US$45,685Oct 15, 2026
Opaleye Management Inc.
10% owner
Buy11,233USD 1.93US$21,735Oct 14, 2026
Opaleye Management Inc.
10% owner
Buy7,215USD 2.02US$14,574Oct 12, 2026
Opaleye Management Inc.
10% owner
Buy5,340USD 2.04US$10,918Oct 9, 2026
Opaleye Management Inc.
10% owner
Buy2,077USD 2.02US$4,190Oct 8, 2026
Opaleye Management Inc.
10% owner
Buy1,694USD 2.06US$3,490Oct 5, 2026
Opaleye Management Inc.
10% owner
Buy20,000USD 2.07US$41,368Oct 2, 2026
Opaleye Management Inc.
10% owner
Buy38,796USD 2.04US$78,961Oct 1, 2026
Opaleye Management Inc.
10% owner
Buy7,849USD 2.09US$16,404Sep 29, 2026
Opaleye Management Inc.
10% owner
Buy5,318USD 2.10US$11,168Sep 23, 2026
Opaleye Management Inc.
10% owner
Buy5,318USD 2.10US$11,168Sep 23, 2026
Opaleye Management Inc.
10% owner
Buy9,771USD 2.10US$20,519Sep 21, 2026
Opaleye Management Inc.
10% owner
Buy9,771USD 2.10US$20,519Sep 21, 2026
Kohli Prashant
Director, Officer: Chief Executive Officer
Buy100,000USD 2.14US$214KSep 9, 2026
Opaleye Management Inc.
10% owner
Buy5,836USD 2.09US$12,197Sep 9, 2026
Opaleye Management Inc.
10% owner
Buy9,393USD 2.10US$19,725Sep 8, 2026
Opaleye Management Inc.
10% owner
Buy11,608USD 2.09US$24,261Aug 14, 2026

Grace Therapeutics, Inc. shareholders